Iodoxamic acid
(Redirected from Endobil)
Iodoxamic acid represents one of the pivotal organoiodine compounds employed in the medical and diagnostic sector. Its hallmark lies in its dual characteristics: a significant iodine content combined with multiple hydrophilic groups. These unique properties make it an invaluable contrast medium in various radiographic studies.
Chemical and Physical Properties[edit | edit source]
Iodoxamic acid boasts a substantial iodine content, allowing it to effectively absorb X-rays. When introduced into the human body, this compound provides a stark contrast in radiographic images, as iodine-rich regions absorb X-rays more proficiently than other biological tissues[1]. Furthermore, the hydrophilic groups present in the molecule enhance its solubility in water. This ensures effective distribution throughout the body and aids in its excretion post the diagnostic procedure.
Clinical Applications[edit | edit source]
Given its radiopaque nature, iodoxamic acid finds its niche in a wide spectrum of diagnostic imaging techniques, including but not limited to:
The primary advantage of utilizing iodoxamic acid in these procedures is its ability to enhance the contrast between the targeted organ or structure and its surroundings, thus sharpening the image quality and aiding in better diagnosis[2].
Pharmacokinetics[edit | edit source]
After administration, iodoxamic acid swiftly disseminates within the circulatory system and the interstitial spaces. As with many contrast agents, its eventual elimination from the body predominantly happens via the renal pathway. Consequently, monitoring and possibly adjusting the dosage becomes paramount in patients with compromised renal function[3].
Adverse Reactions and Safety Profile[edit | edit source]
While iodoxamic acid is generally well-tolerated, medical professionals should be vigilant about potential adverse reactions, which might include:
- Warmth or sensation of heat at the injection site
- Nausea
- Dizziness
More severe reactions, although rare, can comprise:
- Anaphylactic reactions
- Renal impairments
- Cardiovascular events
Prompt medical attention is crucial in case any of these reactions manifest[4].
Conclusion[edit | edit source]
Iodoxamic acid has cemented its position as a potent contrast medium due to its unparalleled ability to enhance radiographic images. Its distinctive chemical structure and high iodine content have made it a stalwart in the world of diagnostic radiology.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
References[edit | edit source]
- Strickland, N. H. (1991). Iodinated contrast media: physical and biological properties. The British Journal of Radiology, 64(767), 923-928.
- Young, S. W., Qing, K., & Camhi, S. L. (2019). Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. Journal of Hepatocellular Carcinoma, 6, 93.
- Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. The New England journal of medicine, 352(3), 239-246.
- Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006). Is there a causal relation between the administration of the iodinated contrast media and the development of renal dysfunction in adults?. Clinical Radiology, 61(4), 301-303.
- ↑ Strickland, N. H. (1991). Iodinated contrast media: physical and biological properties. The British Journal of Radiology, 64(767), 923-928.
- ↑ Young, S. W., Qing, K., & Camhi, S. L. (2019). Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. Journal of Hepatocellular Carcinoma, 6, 93.
- ↑ Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. The New England journal of medicine, 352(3), 239-246.
- ↑ Thomsen, H. S., Morcos, S. K., & Dawson, P. (2006). Is there a causal relation between the administration of the iodinated contrast media and the development of renal dysfunction in adults?. Clinical Radiology, 61(4), 301-303.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
